MSB 10.4% $1.49 mesoblast limited

MSB Trading - 2020, page-12844

  1. 3,960 Posts.
    lightbulb Created with Sketch. 1357
    In regards to @ecoool2 statement weather we choose to believe it or not, it is rather obvious that with CYP's speedy progress any test of IP will be decades away.

    Now to the manufacturing problem that JCR have which is unrelated to the above, could you please post a link. I have seen some info however can't find it again. The statement that I read didn't give any details of what the problem was. In the middle of a pandemic there could be many problems. Revenue from JCR is not large so a slight down turn will not be of any concern.

    Even before the pandemic, SI made a statement that priority would be given to a second manufacturing facility . JCR may be learning a lesson not to be fully reliant on one facility.

    What a shame CYP haven't got a manufacturing problem or do they? If they could manufacture large quantities, better and cheaper than Lonza wouldn't it be wise for them to strike a deal with MSB ?

    Good luck.

  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.